Medtech InsightLiquid biopsy technology is attracting increasing attention from regulators, big manufacturers and investors alike, recent developments in the field show. The diagnostic method allows samples of blood
Medtech InsightUS liquid biopsy firm Biodesix Inc. is expanding its lung cancer diagnostic portfolio and picking up the US assets of UK diagnostics company Oncimmune Ltd. . The agreement is valued at up to $28m o
Scrip[Johnson & Johnson Innovation - JLABS] has been launching its JLABS sites within biotechnology hubs such as Boston, San Diego and San Francisco since 2012, but it chose Philadelphia as the site for it
Medtech InsightDetecting and treating cancer before it invades or metastasizes is the best way to ensure the patient survives the disease. Yet, cancers can be asymptomatic for so long that early detection can be dif